Citations

Clear

3 citation(s) found for "Stevens, Elizabeth".

Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations
Gauckler, Philipp , Fernández‐Juárez, Gema , Floege, Jürgen , Frangou, Eleni , Goumenos, Dimitrios, Kronbichler, Andreas , Fernández-Juárez, Gema , Moura, Marta Casal , Anders, Hans‐Joachim , Bruchfeld, Annette N. , Segelmark, Mårten , Türkmen, Kültiğin , Kooten, Cees van , Tesař, Vladimı́r , Geetha, Duvuru , Fervenza, Fernando C. , Jayne, David , Stevens, Kate

Mayo Clinic

Nephrology Dialysis Transplantation | May 11, 2023 | Volume: 38 | Issue: 11 | Pages: 2637-2651

10.1093/ndt/gfad090 | PMID 37164940 Get It

ABSTRACT Updated guidelines on the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) were released in 2021 by the American College of Rheumatology jointly with the Vasculitis Foundation and, subsequently, in 2022 by the European Alliance of Associations for Rheumatology. In addition, in 2021, the Kidney Disease: Improving Global Outcomes had released updated recommendations on the treatment of AAV with glomerulonephritis (AAV-GN). Kidney involvement is particularly relevant in microscopic polyangiitis and granulomatosis with polyangiitis, but is less frequent in eosinophilic granulomatosis with polyangiitis. The management of AAV-GN has been a focus for drug development and change over the past 10 years. Avoidance of progression to end-stage kidney disease (ESKD) or kidney failure is one of the main unmet needs in the management of AAV, with ESKD having a major impact on morbidity, health costs and mortality risk. Relevant changes in AAV-GN management are related to remission-induction treatment of patients with severe kidney disease, the use of glucocorticoids and avacopan, and remission-maintenance treatment. All the documents provide guidance in accordance with the evidence-based standard of care available at the time of their release. With our work we aim to (i) show the progress made and identify the differences between guidelines and recommendations, (ii) discuss the supporting rationale for those, and (iii) identify gaps in knowledge that could benefit from additional research and should be revised in subsequent updates.
Impact of Affect on Lung Transplant Candidate Outcomes
Pennington, Kelly M. , Benzo, Roberto P. , Schneekloth, Terry D. , Budev, Marie , Chandrashekaran, Satish, Erasmus, D , Levine, Deborah J. , Thompson, Karin L., Novotny, Paul J. , Kennedy, Cassie C. , Erasmus, David B, Thompson, Karin, Stevens, Elizabeth, Kennedy, Cassie C , Lease, Erika D. , Stevens, Elizabeth

Mayo Clinic

Progress in Transplantation | December 16, 2019 | Volume: 30 | Issue: 1 | Pages: 13-21

10.1177/1526924819892921 | PMID 31838950 Get It

Background: We examined the association of adult lung transplant candidates’ self-reported affect with transplant-related outcomes, evaluating whether a positive (vs negative) frame of mind might be protective. Method: Consenting waitlisted candidates from 6 centers completed the questionnaires including the Positive and Negative Affect Schedule annually and posttransplant. Univariate logistic regression analysis was performed to determine the association of baseline affect with outcomes of death or delisting. Models were subsequently adjusted for age, marital status, and education. Results: Questionnaires were completed by 169 candidates (77.9% participation). Mean positive affect, negative affect, and positive-to-negative affect ratio (positivity ratio) were similar to expected norms. The scores of the questionnaire did not change significantly over time. Fifteen (8.9%) waitlisted participants died. Candidates who died while waiting had lower positivity ratios compared to those who survived (1.82 vs 2.45; P = .02). A more negative affect was associated with increased death on the waiting list (adjusted odds ratio [OR] 1.10; P = .021). Conversely, a higher positivity ratio was associated with decreased death while waiting (adjusted OR: 0.45; P = .027). Conclusion: Negative affect may represent a novel risk factor for death on the waitlist. Enhancing positive affect may represent a useful target for psychological optimization in lung transplant candidates.
Feasibility trial of an unsupervised, facility-based exercise programme for depressed outpatients
Patten, Christi A. , Vickers, Kristin S. , Lewis, Beth A. , Finnie, Steven B., Wheeldon, Theresa J., Decker, Paul A. , Stevens, S. Elizabeth, Hathaway, Julie, Reese, Michael, Seime, Richard J., Hathaway, Julie C, Reese, Michael M, Patten, Christi , Decker, Paul A.

Mayo Clinic

Psychology, Health & Medicine | July 26, 2018 | Volume: 24 | Issue: 3 | Pages: 320-332

10.1080/13548506.2018.1499944 | PMID 30047802 Get It